Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 10.885 EUR 2.88% Market Closed
Market Cap: 8B EUR
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Relative Value

The Relative Value of one 87S stock under the Base Case scenario is 5.404 EUR. Compared to the current market price of 10.885 EUR, Roivant Sciences Ltd is Overvalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

87S Relative Value
Base Case
5.404 EUR
Overvaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
12
vs Industry
19
Median 3Y
72
Median 5Y
72
Industry
7.7
Forward
44.9
vs History
5
vs Industry
12
Median 3Y
-3.4
Median 5Y
-3.4
Industry
22.7
Forward
-15.3
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-8.6
Industry
21.6
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-8.4
Industry
25.2
vs History
58
vs Industry
52
Median 3Y
2
Median 5Y
2
Industry
2.5
vs History
38
vs Industry
27
Median 3Y
34.6
Median 5Y
34.6
Industry
7.7
Forward
15.8
vs History
38
vs Industry
23
Median 3Y
40.3
Median 5Y
40.3
Industry
9
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-2.4
Industry
4.2
Forward
-3
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
4.1
Forward
-2.9
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.3
Industry
5.7
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.3
Industry
3.6
vs History
38
vs Industry
34
Median 3Y
4.1
Median 5Y
4.1
Industry
4.6

Multiples Across Competitors

87S Competitors Multiples
Roivant Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Roivant Sciences Ltd
F:87S
8B EUR 105.9 1.7 -2.7 -2.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
UK
Roivant Sciences Ltd
F:87S
Average P/E: 173.9
1.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
UK
Roivant Sciences Ltd
F:87S
Average EV/EBITDA: 17.2
Negative Multiple: -2.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
UK
Roivant Sciences Ltd
F:87S
Average EV/EBIT: 22.5
Negative Multiple: -2.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top